Marc Beer, the former CEO of Aegerion Pharmaceuticals has finally co-founded Renovia Inc., with the intention of developing new products that are aimed at solving the pelvic floor disorders for women. This is a very common condition that has affected and caused pain to a lot of women all over the world. Recently, the CEO of the organization was able to raise more than $42 million that will assist in the accomplishing of the organization’s objectives. The main aim is to enhance health care for women who have been suffering from the pelvic floor disorders for a very long period.
Renovia Inc., a company based in Boston, has developed a range of therapeutic and diagnostic products that are geared towards the treatment of pelvic floor disorders. These are health complications like the urinary incontinence. According to reliable research, this condition affects more than two hundred and fifty million women globally. To curb the spread of the disorder and also to avoid further increase of the statistic, Renovia Inc. has launched its first product that can perform the role. Leva, the new product, has obtained approval by the FDA and was launched in the market in April.
One of the firms that focus on healthcare, The Longwood Fund, made an early investment in Renovia. It also joined hand during the Series B round when the $42 million was raised. The funding was spearheaded by perspective advisers based in New York and the Ascension Ventures, who are located in Missouri. Their principal objective is to innovate, develop and launch several other therapeutic devices that will include enhanced innovations and advancements of the Leva gadget.
During an interview with the local media, Marc Beer stated that he was very grateful for the support that Renovia Inc. had received from the Longwood Fund organization and all the other stakeholders who supported the success of the Series B round. He said that it was a great honor to find out that there were a lot of people out there who shared a common agenda of resolving the agony of millions of women who have been suffering the pain of pelvic floor disorders.
He also stated that his team is well prepared with the right technology which will combine with other factors from the digital health platform to ensure that their customers got reasonable information and data to enable them to discover new options of treatment and also gain deeper understanding and knowledge of pelvic floor disorders. This will enable them to come up with more efficient methods to handle the disorders and subsequently lowering the general cost of health care. Learn more : https://www.slideshare.net/MarcBeer